InsidersTradesSigma
Total declarations
Companies
▲ Purchases (15 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
15
Disclosed sells
0
T+90 hit rate
27%
T+90 mean return
-8.8%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by HOOVER R DAVID, Director. Insider active across 3 companies, notably Elanco Animal Health Inc. Cumulatively, 22 reports have been logged. Breakdown: 15 buys · 0 sell. Total volume traded: €3.6m. Activity tracked since 11 May 2021. The latest transaction was disclosed on 5 March 2025 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations22 total
25,000 shares@ US$10.90237.1% of flowCommon StockSEC:0001415889-25-007410:0
Ideal exit: 30 Nov 2025 (T+270)
18,169 shares0Common StockSEC:0001415889-24-028141:0
20,000 shares@ US$16.14048.3% of flowCommon StockSEC:0001415889-24-007385:0
Ideal exit: 1 Dec 2024 (T+270)
20,374 shares0Common StockSEC:0001415889-23-015773:0
5,000 shares@ US$9.45761.2% of flowCommon StockSEC:0001415889-23-004945:0
Ideal exit: 8 Dec 2023 (T+270)
10,000 shares@ US$11.132.9% of flowCommon StockSEC:0001415889-23-004438:0
Ideal exit: 28 Nov 2023 (T+270)
18,649 shares0Common StockSEC:0001415889-22-011973:0
20,000 shares@ US$15.18078.4% of flowCommon StockSEC:0001415889-22-009498:0
Ideal exit: 6 Jun 2023 (T+270)
10,000 shares@ US$23.32690.0022% mcap8.5% of flowCommon StockSEC:0001415889-22-005599:0
Ideal exit: 14 Feb 2023 (T+270)
5,000 shares@ US$28.66450.0013% mcap4.9% of flowCommon StockSEC:0001179110-22-001943:0
Ideal exit: 26 Nov 2022 (T+270)
10,000 shares@ US$29.37940.0026% mcap10.1% of flowCommon StockSEC:0001179110-21-010543:0
Ideal exit: 27 Aug 2022 (T+270)
10,000 shares@ US$29.37940.0026% mcap23.2% of flowCommon StockSEC:0001179110-21-010543
Ideal exit: 27 Aug 2022 (T+270)
5,000 shares@ US$31.78690.0014% mcap5.4% of flowCommon StockSEC:0001179110-21-010212:0
Ideal exit: 12 Aug 2022 (T+270)
5,000 shares@ US$31.78690.0014% mcap12.4% of flowCommon StockSEC:0001179110-21-010212
Ideal exit: 12 Aug 2022 (T+270)
2,000 shares@ US$30.7450.0005% mcap2.0% of flowCommon StockSEC:0000950138-21-000416:0
Ideal exit: 10 May 2022 (T+270)
2,000 shares@ US$30.7451.5% of flowCommon StockSEC:0000950138-21-000416
Ideal exit: 10 May 2022 (T+270)
25,000 shares@ US$32.440.0067% mcap25.8% of flowCommon StockSEC:0000950138-21-000308:0
Ideal exit: 5 Feb 2022 (T+270)
25,000 shares@ US$32.4425.8% of flowCommon StockSEC:0000950138-21-000308
Ideal exit: 5 Feb 2022 (T+270)
5,290 sharesCommon StockSEC:0001127602-16-040163:0
6,670 sharesCommon StockSEC:0001127602-16-040163:1
6,670 sharesCommon StockSEC:0001127602-16-040163:2
856 sharesCommon StockSEC:0001209191-16-089661:0
22 of 22 declarations
About HOOVER R DAVID
David R. Hoover is a Board Member at Elanco Animal Health Inc. His experience in the animal health sector allows him to provide valuable insights into the strategy and governance of the company.
